Yan Yang

Yan Yang

University of Southern California - Los Angeles / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 5185906
person_outline Yan Yang's MOST POPULAR ARTICLES
1-) Phase I/II study of regorafenib (rego) and pembrolizumab (pembro) in refractory microsatellite stable colorectal cancer (MSSCRC).A Barzi, NS Azad, Y Yang, D Tsao-Wei, R Rehman, M Fakih, S Iqbal, ...Journal of Clinical Oncology 40 (4_suppl), 15-15, 2022342022
2-) Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directionsP Jayachandran, F Battaglin, C Strelez, A Lenz, S Algaze, S Soni, JH Lo, ...Oncogene 42 (9), 627-637, 2023102023
3-) Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentF Battaglin, P Jayachandran, C Strelez, A Lenz, S Algaze, S Soni, JH Lo, ...Oncogene 41 (43), 4769-4778, 202282022
4-) Genetic variants involved in the cGAS-STING pathway predict outcome in patients with metastatic colorectal cancer: Data from FIRE-3 and TRIBE trialsJ Wang, Y Xiao, F Loupakis, S Stintzing, Y Yang, H Arai, F Battaglin, ...European Journal of Cancer 172, 22-30, 202262022
5-) Germline polymorphisms in genes involved in the antioxidant system predict the efficacy of cetuximab in metastatic colorectal cancer patients enrolled in FIRE-3 trialH Arai, J Millstein, Y Yang, S Stintzing, J Wang, F Battaglin, N Kawanishi, ...Clinical Colorectal Cancer 21 (3), 259-266, 202242022